5-methyl-2-[[(4-nitrophenyl)-oxomethyl]hydrazo]-4-thiazolecarboxylic acid ethyl ester : no description available [CHeBI]
Assay ID | Title | Year | Journal | Article |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
dinitrochlorobenzene | | C-nitro compound; monochlorobenzenes | allergen; epitope; sensitiser | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
levoplast | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrobenzaldehyde | | benzaldehydes; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
parathion | | C-nitro compound; organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitropropionic acid | | C-nitro compound | antimycobacterial drug; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor; mycotoxin; neurotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid i | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azathioprine | | aryl sulfide; C-nitro compound; imidazoles; thiopurine | antimetabolite; antineoplastic agent; carcinogenic agent; DNA synthesis inhibitor; hepatotoxic agent; immunosuppressive agent; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bay-k-8644 | | (trifluoromethyl)benzenes; C-nitro compound; dihydropyridine; methyl ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benefin | | C-nitro compound; organofluorine compound; substituted aniline; tertiary amino compound | agrochemical; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dimetridazole | | C-nitro compound; imidazoles | antiparasitic agent; antiprotozoal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
etanidazole | | C-nitro compound; imidazoles; monocarboxylic acid amide | alkylating agent; antineoplastic agent; prodrug; radiosensitizing agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flunitrazepam | | 1,4-benzodiazepinone; C-nitro compound; monofluorobenzenes | anxiolytic drug; GABAA receptor agonist; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl parathion | | C-nitro compound; organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; antifungal agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; genotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metronidazole | | C-nitro compound; imidazoles; primary alcohol | antiamoebic agent; antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; environmental contaminant; prodrug; radiosensitizing agent; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nicardipine | | benzenes; C-nitro compound; diester; dihydropyridine; methyl ester; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
niclosamide | | benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide | anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nifedipine | | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nilutamide | | (trifluoromethyl)benzenes; C-nitro compound; imidazolidinone | androgen antagonist; antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nimesulide | | aromatic ether; C-nitro compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nimetazepam | | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; GABA modulator; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nimodipine | | 2-methoxyethyl ester; C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; isopropyl ester | antihypertensive agent; calcium channel blocker; cardiovascular drug; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nisoldipine | | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; methyl ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitrazepam | | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; drug metabolite; GABA modulator; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitrendipine | | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; ethyl ester; methyl ester | antihypertensive agent; calcium channel blocker; geroprotector; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nizatidine | | 1,3-thiazoles; C-nitro compound; carboxamidine; organic sulfide; tertiary amino compound | anti-ulcer drug; cholinergic drug; H2-receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | | aromatic ether; C-nitro compound; sulfonamide | antineoplastic agent; cyclooxygenase 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxamniquine | | aromatic primary alcohol; C-nitro compound; quinolines; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenylacetic acid | | C-nitro compound; phenylacetic acids | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ronidazole | | C-nitro compound; carbamate ester; imidazoles | antiparasitic agent; antiprotozoal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trifluralin | | (trifluoromethyl)benzenes; C-nitro compound; substituted aniline | agrochemical; environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitroquinoline-1-oxide | | C-nitro compound; quinoline N-oxide | carcinogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloramphenicol | | C-nitro compound; carboxamide; diol; organochlorine compound | antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
niridazole | | 1,3-thiazoles; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dinitrofluorobenzene | | C-nitro compound; organofluorine compound | agrochemical; allergen; chromatographic reagent; EC 2.7.3.2 (creatine kinase) inhibitor; protein-sequencing agent; spectrophotometric reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nifenalol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloropicrin | | C-nitro compound; one-carbon compound; organochlorine compound | antifungal agrochemical; fumigant insecticide; nematicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quintozene | | aromatic fungicide; C-nitro compound; pentachlorobenzenes | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
musk ambrette (artificial) | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-chloro-2-nitrobenzene | | C-nitro compound; monochlorobenzenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
picryl chloride | | C-nitro compound; monochlorobenzenes | allergen; epitope; explosive; hapten | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
picric acid | | C-nitro compound | antiseptic drug; explosive; fixative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-dinitrobenzenesulfonic acid | | arenesulfonic acid; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-nitro-4-methylaniline | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,5-dinitrobenzoic acid | | benzoic acids; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-toluidine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloronitrobenzene | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrobenzyl chloride | | benzyl chlorides; C-nitro compound | mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitroacetophenone | | acetophenones; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tecnazene | | aromatic fungicide; C-nitro compound; tetrachlorobenzene | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-amino-2-nitrotoluene | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-5-nitrothiazole | | C-nitro compound; thiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
naphthol yellow | | C-nitro compound; naphthalenesulfonic acid; naphthols | histological dye | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azomycin | | C-nitro compound; imidazoles | antitubercular agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trinitrobenzenesulfonic acid | | arenesulfonic acid; C-nitro compound | epitope; explosive; reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-nitrobenzaldehyde | | benzaldehydes; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-bromo-2,4-dinitrobenzene | | C-nitro compound; organobromine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,5-dinitrosalicylic acid | | C-nitro compound; monohydroxybenzoic acid | hapten | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,5-dinitrotoluene | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-5-nitroimidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-furaldehyde | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl acetate | | C-nitro compound; phenyl acetates | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylparaoxon | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dinobuton | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrrolnitrin | | alkaloid; C-nitro compound; monochlorobenzenes; pyrroles | antifungal drug; bacterial metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dinoterb | | C-nitro compound; phenols | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-dinitrothiocyanatobenzene | | C-nitro compound; thiocyanates | hapten; tolerogen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4,6-trichlorophenyl 4-nitrophenyl ether | | aromatic ether; C-nitro compound; chlorobenzenes | EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-methylamino-2-nitro-4-n',n'-bis(2-hydroxyethyl)aminobenzene | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitroimidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(alpha-thenoylamino)-2-nitro-5-thiazole | | 1,3-thiazoles; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitroxoline | | C-nitro compound; monohydroxyquinoline | antifungal agent; antiinfective agent; antimicrobial agent; renal agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitralin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,2-epoxy-3-(p-nitrophenoxy)propane | | aromatic ether; C-nitro compound; epoxide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nimorazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-7-nitrobenzofurazan | | benzoxadiazole; C-nitro compound; organochlorine compound | EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.6.1.3 (adenosinetriphosphatase) inhibitor; fluorescent probe; fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ipronidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ornidazole | | C-nitro compound; imidazoles; organochlorine compound; secondary alcohol | antiamoebic agent; antibacterial drug; antiinfective agent; antiprotozoal drug; antitrichomonal drug; epitope | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oryzalin | | aromatic amine; C-nitro compound; sulfonamide; tertiary amino compound | agrochemical; antimitotic; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenitrothion | | C-nitro compound; organic thiophosphate | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzonidazole | | C-nitro compound; imidazoles; monocarboxylic acid amide | antiprotozoal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitro-2-furanyl)methanimine | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitro-1-propanol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amoscanate | | C-nitro compound; isothiocyanate; secondary amino compound | schistosomicide drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
profluralin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dinitramine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hc blue no. 2 | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluchloralin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butralin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isopropalin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pendimethalin | | C-nitro compound; secondary amino compound; substituted aniline | agrochemical; environmental contaminant; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethafluralin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acifluorfen | | aromatic ether; benzoic acids; C-nitro compound; monocarboxylic acid; organochlorine compound; organofluorine compound | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bromethalin | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fomesafen | | aromatic ether; C-nitro compound; monochlorobenzenes; N-sulfonylcarboxamide; organofluorine compound; phenols | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bmy 25067 | | C-nitro compound; organic disulfide | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
musk xylene | | C-nitro compound | carcinogenic agent; explosive; fragrance | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenylalanine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrobenzyl bromide | | benzyl bromides; C-nitro compound | allergen; sensitiser | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitarsone | | C-nitro compound; organoarsonic acid | agrochemical; antiprotozoal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5'-nitro-2'-propoxyacetanilide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cinitapride | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitrouracil | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitrobenzyl alcohol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrobenzyl alcohol | | benzyl alcohols; C-nitro compound | xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
secnidazole | | C-nitro compound; imidazoles; secondary alcohol | epitope | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl palmitate | | C-nitro compound; hexadecanoate ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl butyrate | | butyrate ester; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-nitrophenylacetic acid | | C-nitro compound; phenylacetic acids | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl sulfate | | aryl sulfate; C-nitro compound | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl-alpha-l-fucoside | | alpha-L-fucoside; C-nitro compound | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenylglucuronide | | beta-D-glucosiduronic acid; C-nitro compound | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloramphenicol stearate | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,5-dimethoxy-2-nitrobenzaldehyde | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl beta-d-xyloside | | C-nitro compound; xyloside | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluazinam | | (trifluoromethyl)benzenes; aminopyridine; C-nitro compound; chloropyridine; monochlorobenzenes; secondary amino compound | allergen; antifungal agrochemical; apoptosis inducer; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-nitropropanol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aclonifen | | aromatic ether; C-nitro compound; monochlorobenzenes; primary amino compound; substituted aniline | agrochemical; carotenoid biosynthesis inhibitor; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl beta-d-glucoside | | beta-D-glucoside; C-nitro compound | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl alpha-glucoside | | alpha-D-glucoside; C-nitro compound; monosaccharide derivative | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bnps-skatole | | aryl sulfide; bromoindole; C-nitro compound | reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitrophenylgalactosides | | beta-D-galactoside; C-nitro compound | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-n-(2,4-dinitrophenyl)aminohexanoic acid | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-(1-piperidinyl)pyridine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-(4-nitrobenzyl)glutathione | | C-nitro compound; organic sulfide; S-substituted glutathione | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenyl-2-acetamido-2-deoxy-beta-d-glucopyranoside | | C-nitro compound; N-acetyl-beta-D-glucosaminide | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
miserotoxin | | beta-D-glucoside; C-nitro compound | phytotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid ii | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitisinone | | (trifluoromethyl)benzenes; C-nitro compound; cyclohexanones; mesotrione | EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
efonidipine | | C-nitro compound; carboxylic ester; dihydropyridine; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrrolomycin a | | antibiotic antifungal agent; C-nitro compound; organochlorine compound; pyrroles | antibacterial agent; bacterial metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,8-dinitroimipramine | | C-nitro compound; dibenzoazepine; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-nitrobenzoxadiazole-6-aminohexanoic acid | | benzoxadiazole; C-nitro compound; epsilon-amino acid; secondary amino compound | fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid D | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ag 3-5 | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thymidine 5'-4-nitrophenyl phosphate | | aryl phosphate; C-nitro compound; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid c | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mesotrione | | aromatic ketone; beta-triketone; C-nitro compound; sulfone | carotenoid biosynthesis inhibitor; EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor; environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitrotyrosine | | 2-nitrophenols; C-nitro compound; nitrotyrosine; non-proteinogenic alpha-amino acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[4-(3-methyl-4-nitrophenoxy)butoxy]benzonitrile | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-nitrophenyl)-2-phenoxyacetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rubitecan | | C-nitro compound; delta-lactone; pyranoindolizinoquinoline; semisynthetic derivative; tertiary alcohol | antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-nitro-5-indeno[1,2-b]pyridinone | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(4-nitrophenyl)-4-phenyl-2-thiazolamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(6-methyl-2-pyridinyl)-5-nitro-2-furancarboxamide | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(3,5-dimethyl-1-pyrazolyl)-(2-ethyl-4-nitro-3-pyrazolyl)methanone | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-methyl-2-pyridinyl)-5-nitro-2-furancarboxamide | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-one | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-fluoro-5-nitrophenyl)-2,2-dimethylbutanamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(2-methoxyphenyl)-6-(3-nitrophenyl)-1,4-dihydropyrimidin-2-one | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-ethyl-6-(4-nitrophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxy-7-(4-nitrophenyl)-1,3-benzoxathiol-2-one | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(3,4-dimethoxyphenyl)-3-(2-methoxy-5-nitrophenyl)urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1-ethyl-2-benzimidazolyl)-5-[(4-methyl-2-nitrophenoxy)methyl]-2-furancarboxamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[cyclohexyl(oxo)methyl]amino]-4-(3-nitrophenyl)-3-thiophenecarboxylic acid ethyl ester | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(3-methoxy-5-nitrophenyl)-3-(4-methylphenyl)urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-tert-butyl-3-isoxazolyl)-3-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(2-pyridinyl)acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-methyl-5-nitrophenyl)-4,6-bis(1-pyrrolidinyl)-1,3,5-triazin-2-amine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxy-N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]benzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-2-(4-nitrophenyl)-5-thiazolecarboxylic acid | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-carbamoyl-4-methyl-2-[[(3-nitrophenyl)-oxomethyl]amino]-3-thiophenecarboxylic acid methyl ester | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(3,5-dimethyl-4-nitro-1-pyrazolyl)butanoic acid | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(3-fluorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrophenyl)-4H-pyridine-3,5-dicarboxylic acid diethyl ester | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]-4-methylbenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-dimethyl-5-[[2-[2-(4-nitrophenoxy)ethoxy]phenyl]methylidene]-1,3-diazinane-2,4,6-trione | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
stattic | | 1-benzothiophenes; C-nitro compound; sulfone | antineoplastic agent; radiosensitizing agent; STAT3 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-fluoro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-4-(4,5-dimethoxy-2-nitrophenyl)-7,7-dimethyl-5-oxo-6,8-dihydro-4H-1-benzopyran-3-carbonitrile | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-dichloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N2-tert-butyl-6-ethoxy-N4-(4-nitrophenyl)-1,3,5-triazine-2,4-diamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-methyl-5-[2-(3-nitroanilino)-4-thiazolyl]-2-thiazolyl]acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-N-[5-(4-nitrophenyl)sulfonyl-2-thiazolyl]pentanamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(2-ethyl-1-piperidinyl)-sulfanylidenemethyl]-4-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[3-methoxy-4-[(4-nitrophenyl)methoxy]phenyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-chloro-3-nitrophenyl)-3-phenylbutanamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene | | C-nitro compound; sulfonamide; toluenes | bone density conservation agent; EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor; geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-chlorophenyl)sulfonyl-methylamino]-N-(4-methoxy-2-nitrophenyl)acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2-fluorophenyl)-3-(4-methoxy-2-nitrophenyl)urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(2-nitrophenyl)-N-(2-thiazolyl)-2-furancarboxamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ranitidine | | C-nitro compound; furans; organic sulfide; tertiary amino compound | anti-ulcer drug; drug allergen; environmental contaminant; H2-receptor antagonist; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carnidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-methyl-5-nitro-N-(phenylmethyl)-2-furancarboxamide | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitro-N'-(2,4,6-trichlorophenyl)benzohydrazide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2,2-dimethyl-4-oxanyl)-4-(4-nitrophenyl)thiazole | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methyl-N-(3-methylphenyl)-4-nitro-1H-pyrazol-3-amine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitro-N-[(1-oxopentylhydrazo)-sulfanylidenemethyl]benzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[[[2-(2-methylphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-fluorophenyl)-5-nitro-2-pyridinamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamide | | C-nitro compound; thiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-(1-phenylethylamino)ethyl] ester | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(5-amino-1H-1,2,4-triazol-3-yl)thio]-N-(2-bromo-4-nitrophenyl)acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrophenylhydrazine | | C-nitro compound; phenylhydrazines | mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(1-azepanyl)-6-hydrazinyl-N-(4-nitrophenyl)-1,3,5-triazin-2-amine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-7-methyl-4-(5-nitro-2-furanyl)-5-oxo-4H-pyrano[3,2-c]pyran-3-carbonitrile | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N4-(1,1-dioxo-3-thiolanyl)-5-nitropyrimidine-4,6-diamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N4-(3-chlorophenyl)-N2-methyl-5-nitropyrimidine-2,4,6-triamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrocatechol | | C-nitro compound; catechols | human xenobiotic metabolite; lipoxygenase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(1-naphthalenyl)-3-[[2-(2-nitrophenoxy)-1-oxoethyl]amino]urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nefurthiazole | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-(2,3-dihydro-1,4-dioxin-5-yl)-1,3,4-oxadiazol-2-yl]-5-nitro-2-thiophenecarboxamide | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-aminophenyl)thio]-N-(3-nitrophenyl)acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[4-(2-hydroxyethylamino)-3-nitrophenyl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[6-amino-2-(3-methylanilino)-5-nitro-4-pyrimidinyl]amino]ethanol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N4-(3-fluorophenyl)-N2-[3-(4-morpholinyl)propyl]-5-nitropyrimidine-2,4,6-triamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitro-N-(2-phenylethyl)-2-pyridinamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-nitrophenyl)-4-thiazolecarboxylic acid ethyl ester | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-dinitrophenylhydrazine | | C-nitro compound; phenylhydrazines | reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methyl-N-[[[(4-nitrophenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]butanamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-chlorophenyl)-4-[[(2-methoxy-4-nitroanilino)-sulfanylidenemethyl]hydrazo]-4-oxobutanamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-thiophenecarboxylic acid [1-[(3,5-dichloro-2-pyridinyl)amino]-1-oxopropan-2-yl] ester | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]ethyl]-4-nitroaniline | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrocaramiphen | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(3-methyl-5-nitro-4-imidazolyl)amino]phenol | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-methoxy-4-nitrophenyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N2-(3-methylphenyl)-6-(4-morpholinyl)-5-nitropyrimidine-2,4-diamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sb 415286 | | C-nitro compound; maleimides; monochlorobenzenes; phenols; secondary amino compound; substituted aniline | antioxidant; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide | | C-nitro compound; secondary carboxamide; tertiary carboxamide; trifluoroacetamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[6-amino-2-[3-(dimethylamino)propylamino]-5-nitro-4-pyrimidinyl]amino]ethanol | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(3-chlorophenyl)sulfonyl-N-cyclohexyl-N-methyl-3-nitrobenzamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-(2-methyl-1-piperidinyl)-5-nitro-4-pyrimidinamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(5-nitro-2-thiophenyl)piperidine | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(2,4,6-trinitrophenyl)ethyl]aniline | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-nitro-4-phenylenediamine | | C-nitro compound; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N2-(2-furanylmethyl)-5-nitro-6-(1-pyrrolidinyl)pyrimidine-2,4-diamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2,5-dimethyl-1-prop-2-enyl-3-pyrrolyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]ethanone | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-bromo-4-nitrophenyl)-2-[(5-propan-2-yl-1H-1,2,4-triazol-3-yl)thio]acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2,3-dihydroxypropylamino)-5-nitro-3-pyridinecarbonitrile | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-nitrophenyl)thio]-1-cyclooctanone | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-[[oxo-[(phenylmethyl)amino]methyl]amino]ethyl] ester | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N2-(2-furanylmethyl)-6-(3-methyl-1-piperidinyl)-5-nitropyrimidine-2,4-diamine | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-(4-nitrophenyl)-9-oxo-3-bicyclo[3.3.1]nonanecarbohydrazide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alsterpaullone | | C-nitro compound; caprolactams; organic heterotetracyclic compound | anti-HIV-1 agent; antineoplastic agent; apoptosis inducer; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-fluoro-3-nitrophenyl)-4,4-dimethyl-5H-oxazole | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,2-diamino-4-nitrobenzene | | C-nitro compound; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-[2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]acetyl]-4-nitrobenzohydrazide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
furylfuramide | | acrylamides; C-nitro compound; nitrofuran antibiotic; primary carboxamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cilnidipine | | 2-methoxyethyl ester; C-nitro compound; dihydropyridine | antihypertensive agent; calcium channel blocker; cardiovascular drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ro 61-8048 | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
meptyldinocap | | C-nitro compound; enoate ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
l796778 | | benzenes; C-nitro compound; L-lysine derivative; L-phenylalanine derivative; methyl ester; oligopeptide; secondary carboxamide; ureas | somatostatin receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amocarzine | | C-nitro compound; N-methylpiperazine; secondary amino compound; thioureas | antinematodal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitrovin | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroxymethylfuratrizine | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nifurpirinol | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azanidazole | | C-nitro compound; imidazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aureothin | | 4-pyranones; C-nitro compound; ketene acetal; olefinic compound; oxolanes | antibacterial agent; antifungal agent; antineoplastic agent; antiparasitic agent; bacterial metabolite; EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nidroxyzone | | C-nitro compound; furans | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nifurzide | | C-nitro compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
abt-737 | | aromatic amine; aryl sulfide; biphenyls; C-nitro compound; monochlorobenzenes; N-arylpiperazine; N-sulfonylcarboxamide; secondary amino compound; tertiary amino compound | anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(5-nitrothiazol-2-ylthio)-1,3,4-thiadiazol-2-amine | | 1,3-thiazoles; C-nitro compound; organic sulfide; primary amino compound; thiadiazoles | antibacterial agent; c-Jun N-terminal kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-(2-chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanone | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-nitrophenyl)acetamide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate | | C-nitro compound; spiroketal | antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-morpholinyl)-N'-[(2-nitrophenyl)-oxomethyl]-4-thiazolecarbohydrazide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-[(2-methyl-3-nitrophenyl)-oxomethyl]-2-(4-morpholinyl)-4-thiazolecarbohydrazide | | C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ML-210 | | C-nitro compound; diarylmethane; isoxazoles; monochlorobenzenes; N-acylpiperazine; N-alkylpiperazine; tertiary carboxamide | antineoplastic agent; EC 1.11.1.9 (glutathione peroxidase) inhibitor; ferroptosis inducer; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
abt-199 | | aromatic ether; C-nitro compound; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; N-sulfonylcarboxamide; oxanes; pyrrolopyridine | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chir 98014 | | aminopyrimidine; C-nitro compound; diaminopyridine; dichlorobenzene; imidazoles; secondary amino compound | antineoplastic agent; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; hypoglycemic agent; tau aggregation inhibitor; Wnt signalling activator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acenocoumarol | | C-nitro compound; hydroxycoumarin; methyl ketone | anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-nitroguanosine 3',5'-cyclic monophosphate | | 3',5'-cyclic purine nucleotide; C-nitro compound | biomarker; Brassica napus metabolite; human metabolite; signalling molecule | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |